Assessing energy dynamics and postoperative outcomes in cancer surgery
Official title: A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Run by M.D. Anderson Cancer Center · NCT00493688 · Data updated 2026-11-12
This study is testing a new way to check how well patients with esophageal and lung cancer can handle surgery by measuring their energy levels before the operation to see if it affects their recovery afterwards.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy, radiation |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | October 30, 2005 |
| Main results expected | October 30, 2028 |
| Study ends | October 30, 2028 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT00493688 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with newly diagnosed esophageal or lung cancer undergoing neoadjuvant therapy.
✕Probably not a fit
Patients who are under 18, unable to exercise, or unwilling to participate will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to validate a new method for assessing perioperative risk in patients undergoing major cancer surgery. Researchers will measure preoperative energy reserve capacity using cardiopulmonary exercise testing (CPET) and determine if postoperative morbidity is influenced by perioperative gas exchange metabolism. The primary objective is to characterize the effects of neoadjuvant therapy on functional capacity in patients with esophageal and lung cancer. Secondary objectives include correlating changes in CPET measures with postoperative outcomes following treatment and surgery.
Why it matters
Potential benefit: If successful, this study could improve the assessment of surgical risk and postoperative outcomes for cancer patients.
How similar studies have gone: Other studies have shown success in using CPET to assess perioperative risk, indicating that this approach is supported by existing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants 18 years of age or older. * Participants with newly diagnosed esophageal and lung cancer undergoing neoadjuvant chemotherapy, radiation therapy, and/or immunotherapy. * Participants who have signed the consent form to participate in the study. * Participants must have been evaluated in the Perioperative Evaluation and Management (POEM) Center or by a staff Anesthesiologist. * All laboratory and diagnostic evaluations required or used to evaluate the patient must be completed. All participants must be approved to undergo anesthesia by the standards of the POEM Center. * No samples belonging to vulnerable populations (children, pregnant women, cognitively impaired adults or prisoners) will be allowed from participation. Exclusion Criteria: * Participant is under age 18. * Participant is unwilling to sign consent. * Participant is unable to exercise (bedridden or wheel chair bound). * Participant is enrolled in another study deemed by the investigator to affect oxygen metabolic efficiency and not presently the standard of care at MDACC. * Participant's condition is deemed unsatisfactory for surgery after the preanesthetic evaluation. * Participant has had a myocardial infarction within three months of the preanesthetic evaluation or presents with new or unstable angina. * Participant has a history of a cerebrovascular accident or transit ischemic attacks within three months of the preanesthetic evaluation. * Participant has a history of a pulmonary embolic event within three months of the preanesthetic evaluation. * Participant is known to have acute or chronic deep vein thrombosis. * Participant is pregnant.
Where it's running
-
University of Texas MD Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Anh Dang, MD — M.D. Anderson Cancer Center
- Study coordinator: Anh Q Dang, MD
- Email: adang@mdanderson.org
- Phone: 713-745-5025
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating reconstruction methods after pelvic cancer surgery
This study looks at different ways to rebuild the body after pelvic cancer surgery to see how they affect recovery, quality of life, and healthcare costs for patients.
-
Next Generation Delivery System (NGDS) for SBRT in thorax and upper abdomen
A study tests a new machine to deliver SBRT more quickly and comfortably for adults with thoracic or upper abdominal cancers.
-
Breath-hold technique to improve radiation accuracy for abdominal cancers
This study tests whether using inhale and exhale breath holds during SBRT can better target abdominal tumors while protecting nearby organs.
-
Heated versus aerosolized chemotherapy delivered into the abdomen for cancer that has spread to the peritoneum
This study will test whether heated (HIPEC) or aerosolized (PIPAC) mitomycin-based chemotherapy given into the abdomen works better and is safer for adults whose cancer has spread to the peritoneum.
-
Vaginal Dilator Therapy After Pelvic Radiation
This study tests a new behavioral program to help women who had pelvic radiation use vaginal dilators more regularly.
-
Health-Oriented Protocol for Epidermal Radiodermatitis
This study looks at how skin reactions from radiation therapy affect adults with head/neck or pelvic cancers and whether certain factors influence RID outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.